- Scientists warn against new risks of Ozempic and other popular weight loss drugs The Times of India
- Mapping the effectiveness and risks of GLP-1 receptor agonists Nature.com
- Do GLP-1 drugs have health risks beyond their weight loss benefits? Medical News Today
- GLP-1 Medications: A dual impact on health benefits and side effects The Economic Times
- GLP-1s: Good News, Bad News Medscape
Scientists warn against new risks of Ozempic and other popular weight loss drugs The Times of IndiaMapping the effectiveness and risks of GLP-1 receptor agonists Nature.comDo GLP-1 drugs have health risks beyond their weight loss benefits? Medical News TodayGLP-1 Medications: A dual impact on health benefits and side effects The Economic TimesGLP-1s: Good News, Bad News Medscape Top stories – Google News
